Schedule 13G ownership disclosure
Aegerion Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00767E102
Event date: 2014-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,207,598
- Percent of class
- 10.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-14-001313
- Form type
- SC 13G
- Filer
- Aegerion Pharmaceuticals, Inc.
- CIK
- CIK 1338042
- Filed
- Jul 10, 2014
- Reporting period
- Jun 30, 2014
- Description
- Schedule 13G beneficial ownership